Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC214

Daratumumab

  • Status:
    Veitt
  • Application date:
    1.12.2017
  • Application published:
    15.2.2018
  • Grant published:
    15.10.2019
  • Max expiry date:
    22.3.2031
  • Next due date:
    31.3.2027
  • Medicine name:
    Darzalex
  • Medicine for children:
    No

Timeline

Today
1.12.2017Application
15.2.2018Publication
15.10.2019Registration
31.3.2027Expires

Marketing license

  • IS authorization number:
    EU/1/16/1101/001-002
  • Date:
    27.5.2016
  • Foreign authorization number:
    EU/1/16/1101
  • Date:
    20.5.2016

Owner

  • Name:
    Genmab A/S
  • Address:
    Carl Jacobsens Vej 30, Valby DK

Agent

  • Name:
    Tego ehf.
  • Address:
    Pósthólf 8129, 128 Reykjavík

Patent

Annual fees

Number

Paid

Expires

Payer

Number: 1

Paid: 9.3.2026

Expires: 31.3.2027

Payer: Tego IP ehf.

Upload documents